Accueil › Annuaire des chercheurs › Bernhards Ragama Ogutu
Bernhards Ragama Ogutu
Affiliation : Kenya Medical Research Institute · Strathmore University
- 129Publications (affiliation kényane)
Profil de recherche
Bernhards Ragama Ogutu compte 129 publications référencées (2011–2025). Ses travaux paraissent principalement dans « Malaria Journal », « The Lancet Infectious Diseases » et « The Lancet Global Health ». Son article le plus cité, « Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine » (2015), a été cité 423 fois. 14 de ces publications datent des trois dernières années d’activité. Ses travaux sont cosignés avec au moins 12 chercheurs, notamment dans des établissements de Royaume-Uni, États-Unis, Ouganda, Allemagne.
C’est vous ? Faites connaître vos travaux
Créez gratuitement votre profil DzCademia et ajoutez vos articles : ils apparaîtront plus facilement sur Google et dans les assistants d’IA comme ChatGPT. Plus de personnes pourront vous lire et vous citer.
Créer mon profil gratuit Ajouter mes publicationsPublications (129)
- Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi
- Strengthening the paediatric clinical trial ecosystem to better inform policy and programmes
- Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study
- Slowing artemisinin resistance in Africa
- National research ecosystems: protecting populations and building health security worldwide
- NANOPARTICLE-BASED formulation of dihydroartemisinin-lumefantrine duo-drugs: Preclinical Evaluation and enhanced antimalarial efficacy in a mouse model
- Defining the next generation of severe malaria treatment: a target product profile
- Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study
- Advancing pharmacometrics in Africa—Transition from capacity development toward job creation
- Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum
- Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial
- Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial
- The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum
- Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria
- Reboot biomedical R&D in the global public interest
- Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning
- Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up
- Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria
- Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population
- Community suicide rates and related factors within a surveillance platform in Western Kenya
- The Multistage Antimalarial Compound Calxinin Perturbates P. falciparum Ca2+ Homeostasis by Targeting a Unique Ion Channel
- Low Complexity of Infection Is Associated With Molecular Persistence of Plasmodium falciparum in Kenya and Tanzania
- Performance of a fully‐automated system on a WHO malaria microscopy evaluation slide set
- Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study
- A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria
- Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
- Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders
- Synergism in Antiplasmodial Activities of Artemether and Lumefantrine in Combination with Securidaca longipedunculata Fresen (Polygalaceae)
- Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis
- Towards harmonization of microscopy methods for malaria clinical research studies
- Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- Risk reduction of diarrhea and respiratory infections following a community health education program - a facility-based case-control study in rural parts of Kenya
- Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria
- Communities and Clinical Trials: A Case Study from the RTS,S Malaria Vaccine Trials in Eastern Africa
- African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa
- RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials
- Care-Seeking Dynamics among Patients with Diabetes Mellitus and Hypertension in Selected Rural Settings in Kenya
- The effects of aflatoxin exposure on Hepatitis B-vaccine induced immunity in Kenyan children
- Fully-automated patient-level malaria assessment on field-prepared thin blood film microscopy images
- Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study
- Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
- Clinical trials in low‐resource settings: the perspectives of caregivers of paediatric participants from Uganda, Tanzania and Kenya
- The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries
- True malaria prevalence in children under five: Bayesian estimation using data of malaria household surveys from three sub-Saharan countries
- Dosing of Ceftriaxone and Metronidazole for Children With Severe Acute Malnutrition
- Cause-specific mortality in the Kombewa health and demographic surveillance systems site, rural Western Kenya from 2011–2015
- Malaria, mental disorders, immunity and their inter-relationships - A cross sectional study in a household population in a health and demographic surveillance site in Kenya
- Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
- Computer-Automated Malaria Diagnosis and Quantitation Using Convolutional Neural Networks
- Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries
- Factors associated with malaria microscopy diagnostic performance following a pilot quality-assurance programme in health facilities in malaria low-transmission areas of Kenya, 2014
- Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria
- Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure
- Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria
- Open-source mobile digital platform for clinical trial data collection in low-resource settings
- Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure
- Evaluation of a laboratory quality assurance pilot programme for malaria diagnostics in low-transmission areas of Kenya, 2013
- Malaria and mental disorder: a population study in an area endemic for malaria in Kenya
- Building Capability for Clinical Pharmacology Research in Sub‐Saharan Africa
- Antimalarials: Molecular Drug Targets and Mechanism of Action
- Field evaluation of diagnostic performance of malaria rapid diagnostic tests in western Kenya
- Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial
- Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial
- Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial
- Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria
- Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection
- Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis
- Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
- Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
- Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya
- Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
- Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles
- Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
- Probable Post Traumatic Stress Disorder in Kenya and Its Associated Risk Factors: A Cross-Sectional Household Survey
- Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies
- Common mental disorder in Nyanza province, Kenya in 2013 and its associated risk factors –an assessment of change since 2004, using a repeat household survey in a demographic surveillance site
- Characterization of Plasmodium ovale curtisi and P. ovale wallikeri in Western Kenya Utilizing a Novel Species-specific Real-time PCR Assay
- Alcohol consumption and hazardous drinking in western Kenya—a household survey in a health and demographic surveillance site
- Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study
- Implementation and Operational Research
- Tedium vitae, death wishes, suicidal ideation and attempts in Kenya-prevalence and risk factors
- Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast
- Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria
- Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
- Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine
- Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
- Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles
- Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults
- Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study
- Health & Demographic Surveillance System Profile: The Kombewa Health and Demographic Surveillance System (Kombewa HDSS)
- Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations
- Sample-ready multiplex qPCR assay for detection of malaria
- Fixed dose artesunate amodiaquine – a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine
- A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
- Misclassification of Plasmodium infections by conventional microscopy and the impact of remedial training on the proficiency of laboratory technicians in species identification
- Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01
- Artemether and lumefantrine for the treatment of uncomplicatedPlasmodium falciparummalaria in sub-Saharan Africa
- Fosphenytoin for seizure prevention in childhood coma in Africa: A randomized clinical trial
- Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems
- Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
Revues de publication
- Malaria Journal × 30
- The Lancet Infectious Diseases × 7
- The Lancet Global Health × 4
- BMC Psychiatry × 3
- Trials × 2
- BMC Public Health × 2
Publications par année
- 20255
- 20245
- 20234
- 20228
- 20216
- 20206
- 20198
- 20186
- 201712
- 20167
Collaborations
Établissements partenaires : KEMRI-Wellcome Trust Research Programme · United States Army Medical Research Directorate - Africa · Wellcome Trust · United States Army · University of Oxford
Pays des co-auteurs : Royaume-Uni · États-Unis · Ouganda · Allemagne
Co-auteurs
- Elizabeth A Juma
- Kevin Marsh
- John Michael Ong’echa
- Lucas Otieno
- Charles R. J. C. Newton
- Ben M. Andagalu
- Walter Otieno
- Gilbert O. Kokwaro
- John Njenga Waitumbi
- Peter Sifuna
- Linnet Ongeri
- Raymond Omollo
Données bibliographiques issues d’OpenAlex (base ouverte).
Pourquoi choisir DzCademia ?
Pour donner à vos travaux plus de chances d’être découverts et recommandés par les IA. Profils, articles et communications : donnez à votre recherche une présence publique structurée. Les métadonnées intégrées aident les moteurs de recherche et les assistants IA à identifier vos travaux et à comprendre leurs références.
Commenter avec Google
Connecte-toi avec Google pour commenter directement sur cette page.